Shareholding disclosure
ADDEX THERAPEUTICS LTD
Declared position
67.55%
Threshold
Crossed downwards
Timeline
Published
28.10.2023
Transaction
23.10.2023
Voting rights breakdown
Voting rights acquired33.04%
Voting rights sold67.55%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TANAO00041
Beneficial owner
ADDEX THERAPEUTICS LTD
Declared address
ADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES
On October 23, 2023 Nasdaq got effective the change in ADS ratio from 1 ADXN ADS to 6 ADXN shares to the new ratio of 1 ADXN ADS to 120 ADXN shares. The ADXN ADSs are the underlying of pre-funded warrants and some warrants granted to investors.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open